Shanghai MicroPort EV MedTech Co. Ltd. A Asset Resilience Ratio

Latest as of March 2026: 49.23%

Shanghai MicroPort EV MedTech Co. Ltd. A asset resilience ratio. Shanghai MicroPort EV MedTech Co. Ltd. A (688351) has an Asset Resilience Ratio of 49.23% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai MicroPort EV MedTech Co. Ltd. A (688351) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥983.77 Million
≈ $143.96 Million USD Cash + Short-term Investments

Total Assets

CN¥2.00 Billion
≈ $292.44 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of Shanghai MicroPort EV MedTech Co. Ltd. A (2022–2025)

Asset resilience ratio of Shanghai MicroPort EV MedTech Co. Ltd. A from 2022 to 2025. This chart shows how Shanghai MicroPort EV MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. Read how much debt does Shanghai MicroPort EV MedTech Co. Ltd. A carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai MicroPort EV MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai MicroPort EV MedTech Co. Ltd. A asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥983.77 Million 49.23%
Total Liquid Assets CN¥983.77 Million 49.23%

Asset Resilience Insights

  • Very High Liquidity: Shanghai MicroPort EV MedTech Co. Ltd. A maintains exceptional liquid asset reserves at 49.23% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai MicroPort EV MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai MicroPort EV MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Shanghai MicroPort EV MedTech Co. Ltd. A Asset Resilience Ratio by Year (2022–2025)

Shanghai MicroPort EV MedTech Co. Ltd. A asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Shanghai MicroPort EV MedTech Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 51.53% CN¥1.03 Billion
≈ $150.28 Million
CN¥1.99 Billion
≈ $291.65 Million
-6.00pp
2024-12-31 57.53% CN¥1.09 Billion
≈ $159.41 Million
CN¥1.89 Billion
≈ $277.11 Million
-0.98pp
2023-12-31 58.51% CN¥1.07 Billion
≈ $156.10 Million
CN¥1.82 Billion
≈ $266.80 Million
+9.44pp
2022-12-31 49.07% CN¥879.61 Million
≈ $128.71 Million
CN¥1.79 Billion
≈ $262.30 Million
--
pp = percentage points

About Shanghai MicroPort EV MedTech Co. Ltd. A

SHG:688351 China Medical Devices
Market Cap
$1.24 Billion
CN¥8.48 Billion CNY
Market Cap Rank
#7721 Global
#1680 in China
Share Price
CN¥18.02
Change (1 day)
-2.07%
52-Week Range
CN¥15.99 - CN¥27.52
All Time High
CN¥28.60
About

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robot… Read more